Synthesis and antibacterial activity of novel fluoroquinolones containing substituted piperidines

Bioorganic and Medicinal Chemistry Letters

Volumn 17, Issue 16, 2007, Pages 4523-4526

  Dang, Zhao ^a   Yang, Yushe ^a   Ji, Ruyun ^a   Zhang, Shuhua ^b  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b Sichuan Industrial Institute of Antibiotics   (China)

Author keywords

Antibacterial activity; Fluoroquinolone; Piperidine

Indexed keywords

GEMIFLOXACIN; LINEZOLID; PIPERIDINE DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; DRUG DESIGN; DRUG STRUCTURE; DRUG SUBSTITUTION; DRUG SYNTHESIS; GRAM NEGATIVE BACTERIUM; IN VITRO STUDY; NONHUMAN; SUSTAINED RELEASE PREPARATION;

ANTI-BACTERIAL AGENTS; BACTERIA; FLUOROQUINOLONES; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; PIPERIDINES;

POSIBACTERIA;

EID: 34447338848     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2007.05.093     Document Type: Article

References (16)

1. Hooper D.C. Drugs 49 Suppl. 2 (1995) 10
2. Hoshino K., Kitamura A., Morrissey I., Sato K., Kato J.-I., and Ikeda H. Antimicrob. Agents Chemother. 38 (1994) 2623
3. Bryskier A., and Chantot J.F. Drugs 49 Suppl. 2 (1995) 16
4. Domagala J.M. J. Antimicrob. Chemother. 33 (1994) 685
5. Sanchez J.P., Gogliotti R.D., Domagala J.M., Gracheck S.J., Huband M.D., Sesnie J.A., Cohen M.A., and Shapiro M.A. J. Med. Chem. 38 (1995) 4478
6. Zhanel G.G., Ennis K., Vercaigne L., Walkty A., Gin A.S., Embil J., Smith H., and Hoban D.J. Drugs 62 (2002) 13
7. Takemura S., Miki Y., Uono M., Yoshimura K., Kuroda M., and Suzuki A. Chem. Pharm. Bull. 29 (1981) 3026
8. Grishina G.V., Borisenko A.A., Nosan Z.G., Veselov I.S., Ashkinadze L.D., Karamov E.V., Kornilaeva G.V., and Zefirov N.S. Dokl. Chem. 391 (2003) 195
9. Shono T., Matsumura Y., Uchida K., Tsubata K., and Makino A. J. Org. Chem. 49 (1984) 300
10. Boto A., Hernández R., de León Y., Murguía J.R., and Rodríguez-Afonso A. Tetrahedron Lett. 45 (2004) 6841
11. Tichy M., Sipos J., and Sicher J. Collect. Czech. Chem. Commun. 27 (1962) 2907
12. + (m/e) 328.
13. Parikh J.R., and Doering W.v.E. J. Am. Chem. Soc. 89 (1967) 5505
14. Mich, T.F.U.S. Patent 4, 663, 457, 1987.
15. Hong C.Y., Kim Y.K., Lee Y.H., and Kwak J.H. Bioorg. Med. Chem. Lett. 8 (1998) 221
16. MICs were determined as described by the NCCLS (see National Committee for Clinical Laboratory Standards. 2001. Performance standards for antimicrobial susceptibility testing: 11th informational supplement. Vol. 21, M100-S11. National Committee for Clinical Laboratory Standards, Wayne, PA). The MIC was defined as the lowest concentration of each compound resulting in inhibition of visible growth of bacteria after incubation at 37 °C for 18-24 h.